Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Drug targeting: Anti-HSV-1 activity of mannosylated polymer-bound 9-(2-phosphonylmethoxyethyl)adenine — Patrick Midoux (1990) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Drug targeting: Anti-HSV-1 activity of mannosylated polymer-bound 9-(2-phosphonylmethoxyethyl)adenine
Shared by
De Clercq Erik
KU Leuven
Drug targeting: Anti-HSV-1 activity of mannosylated polymer-bound 9-(2-phosphonylmethoxyethyl)adenine
Article
1990
en
Authors
+7 more
PM
Patrick Midoux
EN
E Nègre
AR
Annie‐Claude Roche
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1994
Therapeutic potential of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) as an antiviral drug
Lieve Naesens
,
Jan Balzarini
,
De Clercq Erik
Article
1992
Pharmacokinetics in mice of the anti-retrovirus agent 9-(2-phosphonylmethoxyethyl)adenine.
Lieve Naesens
,
Jan Balzarini
,
De Clercq Erik
Article
1989
Marked in vivo antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine, a selective anti-human immunodeficiency virus agent.
Jan Balzarini
,
Lieve Naesens
,
Piet Herdewijn
,
Ivan Rosenberg
,
Antonı́n Holý
,
Rudi Pauwels
,
Masanori Baba
,
David G. Johns
,
De Clercq Erik
Article
1991
Immunomodulatory activity of 9-(2-phosphonylmethoxyethyl)adenine (PMEA), a potent anti-HIV nucleotide analogue, on in vivo murine models
V. Del Gobbo
,
Andrea Foli
,
Jan Balzarini
,
De Clercq Erik
,
E Balestra
,
Nicoletta Villani
,
Stefano Marini
,
Carlo Federico Perno
,
R Caliò
Article
1990
Anti‐retrovirus activity of 9‐(2‐phosphonylmethoxyethyl)adenine (pmea) <i>in vivo</i> increases when it is less frequently administered
Jan Balzarini
,
Lieve Naesens
,
De Clercq Erik
Discussion(0)
No comments yet. Be the first to comment.